• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫性胰腺炎的治疗与复发。

Treatment and relapse of autoimmune pancreatitis.

机构信息

Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

出版信息

Gut Liver. 2008 Jun;2(1):1-7. doi: 10.5009/gnl.2008.2.1.1. Epub 2008 Jun 30.

DOI:10.5009/gnl.2008.2.1.1
PMID:20485603
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2871571/
Abstract

Autoimmune pancreatitis (AIP) is a peculiar type of chronic pancreatitis whose pathogenesis involves autoimmune mechanisms. The steroid responsiveness has a significant impact on the diagnosis of AIP because patients with AIP and pancreatic cancer share many clinical features. This review focuses on the treatment and relapse of AIP. The goal of AIP treatment is remission of symptoms, serology, radiologic changes, or histology, which also applies to relapse. Although it is generally agreed that steroids should be offered to AIP patients with active disease, there is no standardized steroid regimen for AIP and no consensus on the dose and duration of steroid induction and tapering schedule, and optimal duration and dose of maintenance therapy. Obtaining a consensus on the optimal treatment regimen is very important to reducing the relapse rate. In this review, we discuss the treatment regimens used in many centers.

摘要

自身免疫性胰腺炎(AIP)是一种特殊类型的慢性胰腺炎,其发病机制涉及自身免疫机制。类固醇反应性对 AIP 的诊断有重要影响,因为 AIP 和胰腺癌患者有许多共同的临床特征。本综述重点介绍 AIP 的治疗和复发。AIP 的治疗目标是缓解症状、血清学、影像学改变或组织学改变,这也适用于复发。尽管人们普遍认为应该为患有活动性疾病的 AIP 患者提供类固醇,但目前尚无 AIP 的标准化类固醇治疗方案,也没有关于类固醇诱导和减量方案的剂量和持续时间以及维持治疗的最佳持续时间和剂量的共识。就最佳治疗方案达成共识对于降低复发率非常重要。在本综述中,我们讨论了许多中心使用的治疗方案。

相似文献

1
Treatment and relapse of autoimmune pancreatitis.自身免疫性胰腺炎的治疗与复发。
Gut Liver. 2008 Jun;2(1):1-7. doi: 10.5009/gnl.2008.2.1.1. Epub 2008 Jun 30.
2
Retrospective study of steroid therapy for patients with autoimmune pancreatitis in a Chinese population.中国人群自身免疫性胰腺炎患者类固醇治疗的回顾性研究。
World J Gastroenterol. 2013 Jan 28;19(4):569-74. doi: 10.3748/wjg.v19.i4.569.
3
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.欧洲 1 型自身免疫性胰腺炎:临床特征和治疗反应。
Clin Gastroenterol Hepatol. 2024 May;22(5):994-1004.e10. doi: 10.1016/j.cgh.2023.12.010. Epub 2024 Jan 5.
4
Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study.对于恶性肿瘤初步检查结果为阴性的患者,进行为期2周的类固醇试验,这对鉴别自身免疫性胰腺炎和胰腺癌是否有用?一项前瞻性结局研究。
Gut. 2008 Dec;57(12):1704-12. doi: 10.1136/gut.2008.150979. Epub 2008 Jun 26.
5
Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients.1 型自身免疫性胰腺炎患者不接受类固醇治疗的临床病程:日本 97 例患者的多中心研究。
J Hepatobiliary Pancreat Sci. 2018 Apr;25(4):223-230. doi: 10.1002/jhbp.541. Epub 2018 Mar 23.
6
Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis.自身免疫性胰腺炎患者复发率的风险因素和类固醇维持治疗的效果:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2019 May;17(6):1061-1072.e8. doi: 10.1016/j.cgh.2018.09.051. Epub 2018 Oct 10.
7
Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids.1型自身免疫性胰腺炎患者接受类固醇治疗后,CT上早期胰腺体积缩小可预测复发。
Orphanet J Rare Dis. 2016 Jul 28;11(1):103. doi: 10.1186/s13023-016-0487-y.
8
Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment.自身免疫性胰腺炎的缓解与复发:聚焦于皮质类固醇治疗。
Pancreas. 2010 Jul;39(5):555-60. doi: 10.1097/MPA.0b013e3181c8b4a5.
9
PrescrAIP: A Pan-European Study on Current Treatment Regimens of Auto-Immune Pancreatitis.PrescrAIP:一项关于自身免疫性胰腺炎当前治疗方案的泛欧研究。
Front Med (Lausanne). 2020 Aug 5;7:408. doi: 10.3389/fmed.2020.00408. eCollection 2020.
10
Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.在一项大型单中心 1 型自身免疫性胰腺炎队列中,复发率和复发的预测因素:短程维持治疗的类固醇治疗后的长期随访结果。
J Gastroenterol. 2018 Aug;53(8):967-977. doi: 10.1007/s00535-018-1434-6. Epub 2018 Jan 23.

引用本文的文献

1
Autoimmune Pancreatitis Associated With Progressive Giant Multilocular Pancreatic Pseudocyst and Steroid-Induced Diabetes.自身免疫性胰腺炎伴进行性巨大多房性胰腺假性囊肿及类固醇诱导的糖尿病
Cureus. 2024 Jul 19;16(7):e64946. doi: 10.7759/cureus.64946. eCollection 2024 Jul.
2
Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors.IgG4相关性硬化性胆管炎激素治疗后复发:影像表现及危险因素
Eur Radiol. 2014 May;24(5):1039-48. doi: 10.1007/s00330-014-3127-8. Epub 2014 Feb 28.
3
Newly developed autoimmune cholangitis without relapse of autoimmune pancreatitis after discontinuing prednisolone.新诊断的自身免疫性胆管炎,停用泼尼松龙后自身免疫性胰腺炎无复发。
World J Gastroenterol. 2012 Nov 7;18(41):5990-3. doi: 10.3748/wjg.v18.i41.5990.
4
Treatment of autoimmune pancreatitis with the anecdotes of the first report.首例报告轶事性记录中自身免疫性胰腺炎的治疗
Int J Rheumatol. 2012;2012:597643. doi: 10.1155/2012/597643. Epub 2012 Apr 3.

本文引用的文献

1
Are regulatory molecules for T cells involved in the development of autoimmune pancreatitis?T细胞的调节分子是否参与自身免疫性胰腺炎的发展?
Am J Gastroenterol. 2008 Mar;103(3):595-6. doi: 10.1111/j.1572-0241.2007.01749.x.
2
Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients.日本患者自身免疫性胰腺炎与细胞毒性T淋巴细胞抗原4基因多态性的关联。
Am J Gastroenterol. 2008 Mar;103(3):588-94. doi: 10.1111/j.1572-0241.2007.01750.x.
3
Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis.利妥昔单抗治疗免疫球蛋白G4相关性胆管炎所致难治性胆管狭窄
Clin Gastroenterol Hepatol. 2008 Mar;6(3):364-6. doi: 10.1016/j.cgh.2007.12.020.
4
Autoimmune pancreatitis, Part II: the relapse.自身免疫性胰腺炎,第二部分:复发
Gastroenterology. 2008 Feb;134(2):625-8. doi: 10.1053/j.gastro.2007.12.014.
5
Pancreatic cancer associated with autoimmune pancreatitis in remission.缓解期与自身免疫性胰腺炎相关的胰腺癌
Intern Med. 2008;47(3):151-5. doi: 10.2169/internalmedicine.47.0334. Epub 2008 Feb 1.
6
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.免疫球蛋白G4相关性胆管炎:临床特征及治疗反应
Gastroenterology. 2008 Mar;134(3):706-15. doi: 10.1053/j.gastro.2007.12.009. Epub 2007 Dec 7.
7
Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis.DQβ1第57位天冬氨酸的替换影响自身免疫性胰腺炎的复发。
Gastroenterology. 2008 Feb;134(2):440-6. doi: 10.1053/j.gastro.2007.11.023. Epub 2007 Nov 17.
8
Is autoimmune pancreatitis a risk factor for pancreatic cancer?自身免疫性胰腺炎是胰腺癌的一个危险因素吗?
Pancreas. 2007 Nov;35(4):376. doi: 10.1097/MPA.0b013e318073ccb8.
9
Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.自身免疫性胰腺炎病例中自发缓解或复发的临床预测因素。
Gastrointest Endosc. 2007 Dec;66(6):1142-51. doi: 10.1016/j.gie.2007.06.059.
10
Optimising corticosteroid treatment for autoimmune pancreatitis.优化自身免疫性胰腺炎的皮质类固醇治疗
Gut. 2007 Dec;56(12):1650-2. doi: 10.1136/gut.2007.129833.